Vas Narasimhan, Novartis CEO (Simon Dawson/Bloomberg via Getty Images)
Novartis unveils 'US-first' strategy ahead of Sandoz spinoff
Weeks after announcing the spinoff of generics arm Sandoz, Vas Narasimhan paints a picture of the new, slimmer Novartis — with a “US-first mindset,” he said …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
